Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange ArcaETF
$99.57
−$2.2371 · -2.20%
As of Oct 8, 11:10 AM ET
Regular session · ET · Market data may be delayed.
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
Fund facts updated Oct 8, 2026.
Day range
Current $99.57
52-week range
Current $99.57
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
1 month
-6.69%
3 months
-3.87%
Year to date
+24.60%
1 year
+37.99%
3 years
+103.28%
5 years
+98.47%
Since inception
+282.23%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 66 reported holdings
Displayed portfolio weight: 35.43%
Holdings data updated Oct 8, 2026.
Dec 20, 2017
Dec 21, 2017
Dec 27, 2017
$0.0723
Annual
Dec 21, 2015
Dec 23, 2015
Dec 29, 2015
$0.397
Annual
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
